Motley Fool Money cover image

Inflation, Retail, Restaurants, and 401K Insights

Motley Fool Money

Shares of Vivint Pharmaceuticals Are Up More Than Forty % This Year.

2min Snip

00:00
Play full episode
Shares were higher after this investor day as they raised their 20 21 profit forecasts. They laid out several strategic initiatives, including pivoting the store footprint to focus on advanced primary care centers and minute clinics. Management expects revenue from covid vaccination and testing to decline 60 to 70 % next year.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode